24.89MUSD
Type
Common Stock
Exchange
NASDAQ
Currency Code
USD
Currency Name
US Dollar
Country Name
USA
Country ISO
US
ISIN
CA74764Y2050
CUSIP
-
Sector
Healthcare
Industry
Biotechnology
Fiscal Year End
December
IPO date
-
Updated At
-
PE Ratio
-
PEG Ratio
-
Book Value
0.10
Dividend Share
-
Dividend Yield
-
Earnings Share
-7.73
Wall Street Target Price
12.52
EPS Estimate Current Year
-2.58
EPS Estimate Next Year
-
EPS Estimate Current Quarter
-0.684
EPS Estimate Next Quarter
-0.586
Most Recent Quarter
-
Revenue TTM
0
Gross Profit TTM
0
EBITDA
-14,327,730
Profit Margin
0.00%
Return On Assets TTM
-62.38%
Return On Equity TTM
-2056.51%
Revenue Per Share TTM
0
Qtly Revenue Growth YOY
0.00%
Diluted Eps TTM
-7.73
Qtly Earnings Growth YOY
0.00%
Trailing PE
0.00
Forward PE
0
Price Sales TTM
91.8563
Price Book MRQ
41.8173
Enterprise Value Revenue
98
Enterprise Value EBITDA
-1
73.80
9.25%17.95
2.98%311.89
0.58%885.00
0.00%144.19
-3.58%862.18
-2.47%601.65
-2.36%435.71
-2.26%291.22
-2.17%151.73
-0.01%